Novo Nordisk - IcoSema internal engagement campaign

Novo Nordisk is due to launch a new product for people with T2D, which combines semaglutide and insulin icodec to overcome barriers previously faced in diabetes treatment.

Our brief was to create a concept and engagement tactics/activities to generate buzz and excitement about IcoSema (not the brand name) internally.